Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Mosenergo in Q1 reduced electricity generation by 3.8%

4/22/25 MSNG

Promomed launched Russia's first drug subscription service

4/22/25 PRMD

Rusal has started testing a new proprietary silicon fertilizer

4/22/25 RUAL

Korshunovsky GOK reports for 2024 by IFRS

4/22/25 KOGK

Arenadata bought general-purpose DBMS Proxima DB

4/22/25 DATA

Severstal reports for 3 months of 2025 by IFRS

4/22/25 CHMF

Severstal's sales in Q1 increased by 7%

4/22/25 CHMF

Astra's Board of Directors approved buyback

4/22/25 ASTR

Sistema consolidated 100% of Niarmedik

4/21/25 AFKS

Board of Directors of Dorogobuzh recommended that dividends be paid for 2024

4/21/25 DGBZ